Impact Factor
4.56
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.69
4,653 total citations
h5-index
79
h5 depth signal
Cited share
86.2%
532 of 617
Total citations
4,653
Citation footprint
Metric signal
7.81
External metric anchor
Self-citation
8.8%
408 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,750
Germany
830
Netherlands
347
France
259
United Kingdom
227
Citing Fields of Research
Prostate Cancer
743
Oncology
696
Radiation & Isotope-Based Techniques
646
Biomedical Physics
603
Neurodegenerative Disorders
270
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,835
Articles tracked across the journal lifetime
Indexed publication set
617
532 cited publications
Last 12 months
386
32.2 publications/month
Open access share
17.9%
69 OA publications in the last year
Leading citing country
United States
1,750 citing publications
Leading citing field
Prostate Cancer
743 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan. 1966-
v7n1, Jan. 1966-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Prostate Cancer
Biomedical Physics
Oncology
Radiation & Isotope-Based Techniques
Gut-Brain Axis Disorders
Neurodegenerative Disorders
Issuing & Sponsoring Bodies
Contributor
Society of Nuclear Medicine (1953- )
Broad Categories
Nuclear Medicine
Prostate Cancer
Immunotherapy
Gut-Brain Axis Disorders
Biomedical Physics
Radiation & Isotope-Based Techniques
Neurodegenerative Disorders
MeSH Descriptors
Nuclear Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.2967/jnumed.125.271912
Open DOI
Multimodal Visual Question Answering System for Survival Prognosis in PSMA-Targeted Radiopharmaceutical Therapy
Large language models show great promise for clinical decision support but generally lack medical imaging integration. Therefore, vision-language models have been proposed, but there is little evidence on their performance, particularly ...
03
DOI 10.2967/jnumed.126.274002
Open DOI
FDA Policy Changes on Stability Studies for PET Drugs Manufactured Within Networks
04
DOI 10.2967/jnumed.126.273904
Open DOI
Streamlining Collaborations to Overcome the Challenges Facing Theranostics Clinical Trials
05
DOI 10.2967/jnumed.126.273553
Open DOI
CD70-Targeted PET/CT in a Patient with von Hippel–Lindau Syndrome and Clear Cell Renal Cell Carcinoma
06
DOI 10.2967/jnumed.125.271971
Open DOI
Design and Development of NeuroSphere PET: A Next-Generation 7-T MR-Compatible Dedicated Brain PET Scanner
PET is the most powerful imaging modality for studying neurotransmitters, receptors, and neuromodulation in humans, complementing the anatomic and hemodynamic information provided by MRI. However, PET temporal resolution remains constrai...
07
DOI 10.2967/jnumed.126.273076
Open DOI
[ 18 F]F-AraG PET Imaging of Immunometabolic Activity in Individuals Without Malignancy
[18F]F-AraG is a clinical-stage PET tracer in immuno-oncology that accumulates in activated T cells and tissues with high mitochondrial biogenesis. Characterizing its distribution in individuals without malignancy is essential for interp...
08
DOI 10.2967/jnumed.126.272891
Open DOI
Test–Retest Repeatability of [ 18 F]FDG Uptake by Solid Tumors on PET/MRI: A Prospective, Multicenter Study Using the QIBA Protocol
Prior oncologic PET/MRI repeatability studies have been limited by single-center designs, small cohorts, or select patient populations. Our primary aim was to estimate the test-retest repeatability of uptake metrics on [18F]FDG PET/MRI s...
09
DOI 10.2967/jnumed.126.272735
Open DOI
Radiopharmaceutical Therapy with [ 177 Lu]Lu-DOTATATE in Refractory Meningiomas: Results from the French Multicenter MELUTE Cohort
Evidence supporting the efficacy and safety of [177Lu]Lu-DOTATATE in refractory meningiomas derives mainly from small, single-center studies. The French national multicenter MELUTE study aimed to consolidate these data using a standardiz...
10
DOI 10.2967/jnumed.126.272939
Open DOI
B7H3-Targeted Molecular Imaging for Highly Specific Diagnosis and In Vivo Noninvasive Detection of B7H3 in Breast Cancer
B7 homolog 3 (B7H3) is widely expressed in solid tumors, but its role in the diagnosis of breast cancer is unclear. We aimed to evaluate the diagnostic performance of [68Ga]Ga-B7H3-BCH PET/CT in breast cancer patients. Methods: Thirty pa...
Bibliographical & Catalog Notes
Issues for <1973-1977> have title: NM.
Issues for <Jan. 1990- > have title: JNM.
Also issued online.
Microfilm. v.10-11, 1969-1970 1 microfilm reel : negative ; 35 mm.
Vol. 29, no. 10 (1988)19910912 Notice published Printed on acid-free paper